Drug Shortage Report for MOXIFLOXACIN INJECTION

Last updated on 2020-05-22 History
Report ID 115558
Drug Identification Number 02433087
Brand name MOXIFLOXACIN INJECTION
Common or Proper name Moxifloxacin Injection 400mg/250ml
Company Name FRESENIUS KABI CANADA LTD
Market Status MARKETED
Active Ingredient(s) MOXIFLOXACIN
Strength(s) 400MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 250 ml
ATC code J01MA
ATC description QUINOLONE ANTIBACTERIALS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2020-05-21
Actual start date 2020-05-21
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2020-05-22
Company comments
Health Canada comments
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2020-05-22 English Compare
v3 2020-05-21 French Compare
v2 2020-05-21 English Compare
v1 2020-05-21 English Compare